NLRP3 and pulmonary fibrosis: In the context of altering the lung tissue expression of NF-κB and the inflammasome NLRP3, the results of the present work regarding the induced (BLM) group and the VCN-treated group were supported by a recently published study on the ameliorating effect of vincamine in pulmonary fibrosis in mice67.